Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2017

Open Access 01-12-2017 | Case report

Successful multimodal treatment of intraoral salivary duct carcinoma in a patient with multiple lymph node metastases: a case report

Authors: Shuichi Imaue, Kei Tomihara, Takeru Hamashima, Gakuto Tomizawa, Kuninori Nomura, Masakiyo Sasahara, Makoto Noguchi

Published in: World Journal of Surgical Oncology | Issue 1/2017

Login to get access

Abstract

Background

Salivary duct carcinoma (SDC) is a high-grade salivary gland malignancy that is associated with an aggressive clinical behavior and poor prognosis. Herein, we report on a long surviving case of SDC of the minor salivary gland with multiple lymph node metastases (LNMs).

Case presentation

An 83-year-old woman presented with a history of lymphadenopathy in the right side of the neck and recent onset and rapid growth of a mass in the right buccal region. Clinical examinations and biopsy findings were suggestive of a salivary gland malignant tumor with regional LNMs. The patient was treated with neoadjuvant chemotherapy. Tumor excision and ipsilateral radical neck dissection were performed, followed by adjuvant chemoradiotherapy. Postoperative histological examination revealed a tumor with irregular nests of atypical ductal epithelial cells, a cribriform growth pattern, and comedo-like central necrosis that lead to a final diagnosis of SDC. LNMs were observed in six lymph nodes of the right side of the neck. The patient underwent postoperative chemotherapy using single-agent cisplatin that was administered concurrently with radiotherapy (total, 65 Gy). There was no evidence of local recurrence or distant metastasis for >6 years.

Conclusions

Although available data on treatment modalities for SDC remain limited, multimodal therapy may contribute to improved clinical outcomes in patients with advanced intraoral SDC.
Literature
1.
go back to reference Kleinsasser O, Klein HJ, Hübner G. Salivary duct carcinoma. A group of salivary gland tumors analogous to mammary duct carcinoma. Arch Klin Exp Ohren Nasen Kehlkopfheilkd. 1968;192:100–5.CrossRefPubMed Kleinsasser O, Klein HJ, Hübner G. Salivary duct carcinoma. A group of salivary gland tumors analogous to mammary duct carcinoma. Arch Klin Exp Ohren Nasen Kehlkopfheilkd. 1968;192:100–5.CrossRefPubMed
2.
go back to reference Seifert G, Sobin LH. Histological typing of salivary gland tumours, 2nd ed, World Health Organization International Histological Classification of Tumours. Berlin, Germany: Springer-Verlag; 1991.CrossRef Seifert G, Sobin LH. Histological typing of salivary gland tumours, 2nd ed, World Health Organization International Histological Classification of Tumours. Berlin, Germany: Springer-Verlag; 1991.CrossRef
3.
go back to reference Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Löning T. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer. 2005;103:2526–33.CrossRefPubMed Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Löning T. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer. 2005;103:2526–33.CrossRefPubMed
4.
go back to reference Jayaprakash V, Merzianu M, Warren GW, et al. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: analysis of 228 cases from the Surveillance, Epidemiology, and End results database. Head Neck. 2014;36:694–701.CrossRefPubMed Jayaprakash V, Merzianu M, Warren GW, et al. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: analysis of 228 cases from the Surveillance, Epidemiology, and End results database. Head Neck. 2014;36:694–701.CrossRefPubMed
5.
go back to reference Otsuka K, Imanishi Y, Tada Y, et al. Clinical outcomes and prognostic factors for salivary duct carcinoma: a multi-institutional analysis of 141 patients. Ann Surg Oncol. 2016;23:2038–45.CrossRefPubMedPubMedCentral Otsuka K, Imanishi Y, Tada Y, et al. Clinical outcomes and prognostic factors for salivary duct carcinoma: a multi-institutional analysis of 141 patients. Ann Surg Oncol. 2016;23:2038–45.CrossRefPubMedPubMedCentral
6.
go back to reference Wee DT, Thomas AA, Bradley PJ. Salivary duct carcinoma: what is already known, and can we improve survival? J Laryngol Otol. 2012;126 Suppl 2:S2–7.CrossRefPubMed Wee DT, Thomas AA, Bradley PJ. Salivary duct carcinoma: what is already known, and can we improve survival? J Laryngol Otol. 2012;126 Suppl 2:S2–7.CrossRefPubMed
7.
go back to reference Shinoto M, Shioyama Y, Nakamura K, et al. Postoperative radiotherapy in patients with salivary duct carcinoma: clinical outcomes and prognostic factors. J Radiat Res. 2013;54:925–30.CrossRefPubMedPubMedCentral Shinoto M, Shioyama Y, Nakamura K, et al. Postoperative radiotherapy in patients with salivary duct carcinoma: clinical outcomes and prognostic factors. J Radiat Res. 2013;54:925–30.CrossRefPubMedPubMedCentral
8.
go back to reference Nakashima T, Yasumatsu R, Toh S, et al. Is there a role of adjuvant treatment for salivary duct carcinoma? J Laryngol Otol. 2015;129 Suppl 2:S98–101.CrossRefPubMed Nakashima T, Yasumatsu R, Toh S, et al. Is there a role of adjuvant treatment for salivary duct carcinoma? J Laryngol Otol. 2015;129 Suppl 2:S98–101.CrossRefPubMed
9.
go back to reference Pons Y, Alves A, Clément P, Conessa C. Salivary duct carcinoma of the parotid. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128:194–6.CrossRefPubMed Pons Y, Alves A, Clément P, Conessa C. Salivary duct carcinoma of the parotid. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128:194–6.CrossRefPubMed
10.
go back to reference Urban SD, Hall JM, Bentkover SH, Kadish SP. Salivary duct carcinoma of minor salivary gland origin: report of a case involving the cavernous sinus. J Oral Maxillofac Surg. 2002;60:958–62.CrossRefPubMed Urban SD, Hall JM, Bentkover SH, Kadish SP. Salivary duct carcinoma of minor salivary gland origin: report of a case involving the cavernous sinus. J Oral Maxillofac Surg. 2002;60:958–62.CrossRefPubMed
11.
go back to reference Brandwein MS, Jagirdar J, Patil J, Biller H, Kaneko M. Salivary duct carcinoma (cribriform salivary carcinoma of excretory ducts). A clinicopathologic and immunohistochemical study of 12 cases. Cancer. 1990;65:2307–14.CrossRefPubMed Brandwein MS, Jagirdar J, Patil J, Biller H, Kaneko M. Salivary duct carcinoma (cribriform salivary carcinoma of excretory ducts). A clinicopathologic and immunohistochemical study of 12 cases. Cancer. 1990;65:2307–14.CrossRefPubMed
12.
go back to reference Huh KH, Heo MS, Lee SS, Choi SC. Three new cases of salivary duct carcinoma in the palate: a radiologic investigation and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:752–60.CrossRefPubMed Huh KH, Heo MS, Lee SS, Choi SC. Three new cases of salivary duct carcinoma in the palate: a radiologic investigation and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:752–60.CrossRefPubMed
13.
go back to reference Guzzo M, Locati LD, Prott FJ, Gatta G, McGurk M, Licitra L. Major and minor salivary gland tumors. Crit Rev Oncol Hematol. 2010;74:134–48.CrossRefPubMed Guzzo M, Locati LD, Prott FJ, Gatta G, McGurk M, Licitra L. Major and minor salivary gland tumors. Crit Rev Oncol Hematol. 2010;74:134–48.CrossRefPubMed
14.
go back to reference Simpson RH. Salivary duct carcinoma: new developments—morphological variants including pure in situ high grade lesions; proposed molecular classification. Head Neck Pathol. 2013;7 Suppl 1:S48–58.CrossRefPubMed Simpson RH. Salivary duct carcinoma: new developments—morphological variants including pure in situ high grade lesions; proposed molecular classification. Head Neck Pathol. 2013;7 Suppl 1:S48–58.CrossRefPubMed
15.
go back to reference Prat A, Parera M, Reyes V, et al. Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy. Head Neck. 2008;30:680–3.CrossRefPubMed Prat A, Parera M, Reyes V, et al. Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy. Head Neck. 2008;30:680–3.CrossRefPubMed
16.
go back to reference Kaidar-Person O, Billan S, Kuten A. Targeted therapy with trastuzumab for advanced salivary ductal carcinoma: case report and literature review. Med Oncol. 2012;29:704–6.CrossRefPubMed Kaidar-Person O, Billan S, Kuten A. Targeted therapy with trastuzumab for advanced salivary ductal carcinoma: case report and literature review. Med Oncol. 2012;29:704–6.CrossRefPubMed
17.
go back to reference Jaspers HC, Verbist BM, Schoffelen R, et al. Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options. J Clin Oncol. 2011;29:e473–476.CrossRefPubMed Jaspers HC, Verbist BM, Schoffelen R, et al. Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options. J Clin Oncol. 2011;29:e473–476.CrossRefPubMed
Metadata
Title
Successful multimodal treatment of intraoral salivary duct carcinoma in a patient with multiple lymph node metastases: a case report
Authors
Shuichi Imaue
Kei Tomihara
Takeru Hamashima
Gakuto Tomizawa
Kuninori Nomura
Masakiyo Sasahara
Makoto Noguchi
Publication date
01-12-2017
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2017
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-016-1090-3

Other articles of this Issue 1/2017

World Journal of Surgical Oncology 1/2017 Go to the issue